These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 9292403

  • 1. Single-point phenytoin dosage predictions in Singapore Chinese.
    Chan E.
    J Clin Pharm Ther; 1997 Feb; 22(1):47-52. PubMed ID: 9292403
    [Abstract] [Full Text] [Related]

  • 2. Phenytoin dosage predictions in paediatric patients.
    Yuen GJ, Latimer PT, Littlefield LC, Mackey RW.
    Clin Pharmacokinet; 1989 Apr; 16(4):254-60. PubMed ID: 2721089
    [Abstract] [Full Text] [Related]

  • 3. Predictive performance of pharmacokinetic methods for phenytoin dosing: a multi-center evaluation in 282 patients with epilepsy.
    Zaccara G, Messori A, Muscas GC, Albani F, Baruzzi A, Bianchi A, Riva R, Valenza T, Zagnoni P, Zolo P.
    Epilepsy Res; 1989 Apr; 3(3):253-61. PubMed ID: 2659322
    [Abstract] [Full Text] [Related]

  • 4. Estimation of Phenytoin Pharmacokinetic Parameters in Saudi Epileptic Patients.
    Alqahtani S, Alzaidi T, Alotaibi M, Alsultan A.
    Pharmacology; 2019 Apr; 104(1-2):60-66. PubMed ID: 31067540
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of single-point phenytoin dosage prediction methods in pediatric patients.
    Yukawa E, Higuchi S, Aoyama T.
    J Pharmacobiodyn; 1988 Nov; 11(11):736-43. PubMed ID: 3236206
    [Abstract] [Full Text] [Related]

  • 6. Systematic approach to a dosage regimen for phenytoin based on one-point, steady-state plasma concentration.
    Nakashima E, Matsushita R, Kido H, Nakamura M, Asahi M, Ichimura F.
    Ther Drug Monit; 1995 Feb; 17(1):12-8. PubMed ID: 7725371
    [Abstract] [Full Text] [Related]

  • 7. Preliminary study of the association between the elimination parameters of phenytoin and phenobarbital.
    Methaneethorn J, Panomvana D, Vachirayonstien T.
    Drug Metab Pers Ther; 2017 Sep 26; 32(3):151-156. PubMed ID: 28873066
    [Abstract] [Full Text] [Related]

  • 8. A Bayesian graphic method for predicting individual phenytoin dosage schedule.
    Cai WM, Chu XM, Chen G.
    Zhongguo Yao Li Xue Bao; 1991 Mar 26; 12(2):141-4. PubMed ID: 1776478
    [Abstract] [Full Text] [Related]

  • 9. Three Michaelis-Menten pharmacokinetic dosing methods compared with physician dosing of phenytoin in an outpatient neurology practice.
    Spruill WJ, Wade WE, Cobb HH, Akbari S.
    Pharmacotherapy; 2001 Nov 26; 21(11):1407-14. PubMed ID: 11714214
    [Abstract] [Full Text] [Related]

  • 10. Comparison of methods for the prediction of phenytoin concentrations.
    Vázquez Rodríguez A, Santos Buelga D, Alonso González AC, Garcćia Sánchez MJ, Domínguez-Gil Hurlé A.
    J Clin Pharm Ther; 1991 Feb 26; 16(1):55-62. PubMed ID: 2026669
    [Abstract] [Full Text] [Related]

  • 11. Development of a population pharmacokinetic model for carbamazepine based on sparse therapeutic monitoring data from pediatric patients with epilepsy.
    Carlsson KC, Hoem NO, Glauser T, Vinks AA.
    Clin Ther; 2005 May 26; 27(5):618-26. PubMed ID: 15978311
    [Abstract] [Full Text] [Related]

  • 12. Optimal Dosing Regimen of Phenytoin for Korean Epilepsy Patients: From Premature Babies to the Elderly.
    Guk J, Lee SG, Chae D, Kim JH, Park K.
    J Pharm Sci; 2019 Aug 26; 108(8):2765-2773. PubMed ID: 30940470
    [Abstract] [Full Text] [Related]

  • 13. Predicting phenytoin dosages using Bayesian feedback: a comparison with other methods.
    Yuen GJ, Taylor JW, Ludden TM, Murphy MJ.
    Ther Drug Monit; 1983 Aug 26; 5(4):437-41. PubMed ID: 6659016
    [Abstract] [Full Text] [Related]

  • 14. Optimization of phenytoin therapy in adults with epilepsy in the Western Cape, South Africa.
    Valodia PN, Seymour MA, Kies BM, Folb PI.
    J Clin Pharm Ther; 1999 Oct 26; 24(5):381-5. PubMed ID: 10583702
    [Abstract] [Full Text] [Related]

  • 15. Therapeutic Drug Monitoring of Phenytoin by Simple, Rapid, Accurate, Highly Sensitive and Novel Method and Its Clinical Applications.
    Shaikh AS, Guo R.
    Curr Pharm Biotechnol; 2017 Oct 26; 18(13):1098-1105. PubMed ID: 29437004
    [Abstract] [Full Text] [Related]

  • 16. Nonparametric population modeling of valproate pharmacokinetics in epileptic patients using routine serum monitoring data: implications for dosage.
    Bondareva IB, Jelliffe RW, Sokolov AV, Tischenkova IF.
    J Clin Pharm Ther; 2004 Apr 26; 29(2):105-20. PubMed ID: 15068399
    [Abstract] [Full Text] [Related]

  • 17. Validation of population pharmacokinetic parameters of phenytoin using the parallel Michaelis-Menten and first-order elimination model.
    Valodia PN, Seymour MA, McFadyen ML, Miller R, Folb PI.
    Ther Drug Monit; 2000 Jun 26; 22(3):313-9. PubMed ID: 10850399
    [Abstract] [Full Text] [Related]

  • 18. Phenytoin dosage adjustment in Saudi epileptics: utilization of steady-state pharmacokinetic parameters.
    Abduljabbar M, Al-Khamis K, Ogunniyi A, Daif AK, Al-Yamani M.
    Eur J Neurol; 1999 May 26; 6(3):331-4. PubMed ID: 10210914
    [Abstract] [Full Text] [Related]

  • 19. Influence of bioavailability on the calculated Michaelis-Menten parameters of phenytoin in children.
    Koren G, Brand N, MacLeod SM.
    Ther Drug Monit; 1984 May 26; 6(1):11-4. PubMed ID: 6710554
    [Abstract] [Full Text] [Related]

  • 20. Comparison of single-point phenytoin dosage prediction techniques.
    Yukawa E, Higuchi S, Ohtsubo K, Aoyama T.
    J Clin Pharm Ther; 1988 Aug 26; 13(4):293-305. PubMed ID: 3235480
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.